Table 1.
Patient Characteristics, Treatment, and Outcome
| Patient (age, sex) | Side/Year/Histology | Previous treatment | Resection status | Adjuvant treatment | Recurrence site | Outcome, follow-up |
|---|---|---|---|---|---|---|
| 1 (34, F) | Rt/2005/B1+B2 | None | Complete | None | Peritoneum 13 mo | DOD, 25 mo |
| 2 (58, M) | Rt/2005/B2 | S/adjuvant RT (54Gy) | Complete | None | None | Dead, pneumonia, 27 mo |
| 3 (35, M) | Rt/2006/B2+B3 | S (sternotomy, stage III) | Complete | CT (CAP) | None | NED, 40 mo |
| 4 (65, F) | Lt/2007/B2 | CT (CAV #2, VIP #10) | Incomplete | CT+RT (60Gy) | Mediastinum, pleura | DOD, 31 mo |
| 5 (49, F) | Lt/2007/B1+B2 | CT (docetaxel, cisplatin) | Complete | CT (CAP) | None | NED, 27 mo |
| 6 (50, M) | Rt/2007/B2+B3 | CT (docetaxel, cisplatin) | Complete | CT (CAP) | None | NED, 24 mo |
| 7 (52, M) | Lt/2008/B3 | CT (docetaxel, cisplatin) | Complete | CT (CAP) | None | NED, 13 mo |
DOD, dead of disease; NED, no evidence of disease;
S, surgery; RT, radiotherapy; CT, chemotherapy;
CAP, cyclophosphamide, doxorubicin, cisplatin; CAV, cyclophosphamide, doxorubicin, vincristine;
VIP, etoposide, ifosfamide, cisplatin.